Ginsenosides: Allies of gastrointestinal tumor immunotherapy
In the past decade, immunotherapy has been the most promising treatment for gastrointestinal tumors. But the low response rate and drug resistance remain major concerns. It is therefore imperative to develop adjuvant therapies to increase the effectiveness of immunotherapy and prevent drug resistanc...
Saved in:
Main Authors: | Yutao Feng (Author), Fen Ma (Author), Enjiang Wu (Author), Zewei Cheng (Author), Zhengtao Wang (Author), Li Yang (Author), Jiwei Zhang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Progress in the application of hydrogels in immunotherapy of gastrointestinal tumors
by: Hao Zheng, et al.
Published: (2023) -
Ginsenosides in Panax genus and their biosynthesis
by: Maoqi Hou, et al.
Published: (2021) -
Gastrointestinal stromal tumor: Role of surgery and immunotherapy
by: Bhatnagar Sushmita
Published: (2010) -
Gut Microbiota: Novel Therapeutic Target of Ginsenosides for the Treatment of Obesity and Its Complications
by: Tongxi Zhuang, et al.
Published: (2021) -
CD74 facilitates immunotherapy response by shaping the tumor microenvironment of hepatocellular carcinoma
by: Jianghong Cheng, et al.
Published: (2024)